SCHEDULE 13G: BlackRock Discloses 11.4% Passive Stake in Astrana Health, Inc.
Beneficial Ownership Report
BlackRock, Inc. has reported a beneficial ownership of 11.4% of Astrana Health, Inc.'s common stock, totaling 6,433,206 shares, as of December 31, 2024, indicating a passive investment.
Summary
- BlackRock, Inc. reported beneficial ownership of 6,433,206 shares of Astrana Health, Inc. common stock.
- This represents 11.4% of the total class of securities.
- The filing date for this Schedule 13G was February 5, 2025, reflecting ownership as of December 31, 2024.
- BlackRock, Inc. holds sole voting power over 6,377,659 shares and sole dispositive power over all 6,433,206 shares.
- The shares are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing control of the issuer.
- Several BlackRock subsidiaries, including BlackRock Fund Advisors, beneficially own 5% or greater of the outstanding shares of Astrana Health, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing beneficial ownership. It contains factual information and does not convey positive or negative sentiment regarding the issuer's performance or outlook, beyond the implicit signal of a large institutional investment.
Positives
- A significant stake (11.4%) held by a major institutional investor like BlackRock can signal confidence in Astrana Health, Inc.'s long-term prospects.
- The passive nature of the investment (Rule 13d-1(b) filing) suggests BlackRock is not seeking to influence management or control, which can be viewed positively by current management.
Negatives
- The document itself does not contain any negative information regarding Astrana Health, Inc. or BlackRock's investment.
Risks
- The filing indicates a passive investment, meaning BlackRock is not seeking to influence control, which could be a risk if the company requires active shareholder engagement for strategic changes.
- As with any investment, the value of BlackRock's stake is subject to market fluctuations and the performance of Astrana Health, Inc.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding Astrana Health, Inc.'s future performance or BlackRock's investment strategy beyond the passive nature of the holding.
Industry Context
BlackRock, as one of the world's largest asset managers, routinely files Schedule 13G reports to disclose its passive ownership stakes in publicly traded companies across various sectors, including healthcare. This filing is consistent with its role as a major institutional investor managing assets for numerous clients.
Comparison to Industry Standards
- This filing is a standard disclosure for an institutional investor holding more than 5% of a company's shares, aligning with SEC regulations.
- BlackRock's 11.4% stake in Astrana Health, Inc. is a significant passive position, typical for large asset managers who invest across a broad portfolio.
- The document does not provide specific comparable companies, projects, or results to assess against industry benchmarks.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. updated its Power of Attorney, appointing several individuals as attorneys-in-fact for executing and filing ownership or control-person reporting requirements, including SEC forms. This new power of attorney, dated January 21, 2025, expressly revokes the previous one dated April 30, 2023. | 01/21/2025 | Streamlines the process for BlackRock to comply with various regulatory reporting requirements for its extensive investment holdings. |
Stakeholder Impact
- Shareholders: May view BlackRock's significant passive stake as a vote of confidence, potentially contributing to stability or positive sentiment.
- Management: The passive nature of the stake indicates BlackRock is not seeking to influence control, which generally means less pressure from this specific large shareholder on operational decisions.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (end of reporting period). |
| 01/21/2025 | Date of execution of the Power of Attorney by BlackRock, Inc. |
| 02/05/2025 | Date of signing of the Schedule 13G by BlackRock, Inc. |
Keywords
Astrana Health, BlackRock, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, healthcare, asset management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.